Brief: India Globalization Capital Inc - Enrolling Participants Suffering From Mild To Severe Dementia Due To Alzheimer's Disease For Its Phase 1 Clinical Trial

IGC Pharma

23/11/2020 14:21

Nov 23 (Reuters) - India Globalization Capital Inc  IGC.A :
    * INDIA GLOBALIZATION CAPITAL - ENROLLING PARTICIPANTS
SUFFERING
FROM MILD TO SEVERE DEMENTIA DUE TO ALZHEIMER'S DISEASE FOR ITS
PHASE 1 CLINICAL TRIAL
    * INDIA GLOBALIZATION CAPITAL - EXPECT TO COMPLETE PHASE 1
STUDY
DURING H1 OF CALENDAR 2021

Source text for Eikon:  ID:nBw7bKDvPa 
Further company coverage:  IGC.A 

 ((Reuters.Briefs@thomsonreuters.com;))